Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2026-06-22 16:32:08 ET · period of report 2026-06-17 · accession 0001601830-26-000083 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-22 16:32 | 2026-06-17 | RXRX | Li Dean Y | Dir | A - Grant | $0.00 | +88.4K | 1.47M | +6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-06-17 | A | A | 88,424 | $0.00 | 1,469,582 | D | — | — | (F1) Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 17,2027 or the day prior to the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer. (F2) Includes 136,981 shares of Class A common stock transferred from the Dean Y. Li GRAT on May 7, 2026. |